Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,746 GBX | +0.37% | -2.35% | +20.43% |
05-28 | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
05-27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.43% | 90.67B | |
+38.61% | 727B | |
+30.57% | 592B | |
-7.72% | 347B | |
+15.48% | 319B | |
-0.42% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.32% | 160B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Deutsche Bank Keeps GSK At Hold, Boosts PT